Company Description

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States.

Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum.

It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.

Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Ginkgo Bioworks Holdings, Inc.

Country	United States
Founded	2008
Industry	Biotechnology
Sector	Healthcare
Employees	1,218
CEO	Dr. Jason Kelly

Contact Details

Address: 27 Drydock Avenue, 8th Floor Boston, Massachusetts 02210 United States
Phone	(877) 442-5362
Website	ginkgobioworks.com

Stock Details

Ticker Symbol	DNA
Exchange	NYSE
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001830214
CUSIP Number	37611X100
ISIN Number	US37611X1000
Employer ID	87-2652913
SIC Code	2836

Key Executives

Name	Position
Dr. Jason Kelly	Founder, Chief Executive Officer and Director
Dr. Reshma P. Shetty	Founder, President, Chief Operating Officer and Director
Mark E. Dmytruk	Chief Financial Officer
Thomas Knight Jr.	Founder
Austin Che	Founder, Head of Strategy and Treasurer
Bartholomew Canton	Founder, Chief Technology Officer and Secretary
Steven P. Coen CPA	Chief Accounting Officer
Karen Tepichin	General Counsel and Secretary
Anna Marie Wagner	Senior Vice President of Corporate Development
Samantha Sutton	Head of People

Latest SEC Filings

Date	Type	Title
Apr 22, 2024	144	Filing
Apr 19, 2024	144	Filing
Apr 18, 2024	144	Filing
Apr 17, 2024	144	Filing
Apr 16, 2024	144	Filing
Apr 15, 2024	144	Filing
Apr 12, 2024	144	Filing
Apr 11, 2024	144	Filing
Apr 10, 2024	144	Filing
Apr 9, 2024	144	Filing

View All SEC Filings